Domino's Pizza, Inc.

DPZ Q3 2026

Reported: 2026-10-15

Domino’s shares fell 4.8% after earnings, with investors likely focused on management’s warning that consumer pressure will remain an overhang through the rest of 2026. The company cited continued order growth, but offered no quantified outlook in the provided remarks to offset that caution.

Key takeaways

Management said orders increased in both delivery and carryout, and that Domino’s continued to gain share in the QSR pizza category; it did not provide figures for either.
CEO Joe Jordan expects the macro environment to weigh on consumers through year-end, while saying the company has a strong fourth-quarter calendar and is positioned to compete.
Jordan identified getting closer to customers and sustaining strong four-wall franchisee profitability as his two priorities.
The Domino, a new product aimed at group occasions with individual choice, is intended to broaden appeal, particularly on aggregator platforms.
Russell Weiner plans to become executive chairman at the annual shareholder meeting in April; Jordan, a 15-year company veteran, has taken over as CEO.

View recap

Johnson & Johnson

JNJ Q3 2026

Reported: 2026-10-15

Johnson & Johnson shares fell 3.7% after earnings, despite 6% operational sales growth, as the call offered no clear evidence of a guidance cut or specific shortfall to explain the reaction. Management said the company remained on track to meet its 2026 outlook, but that reassurance may not have been enough to offset investor concerns not detailed in the available transcript.

Key takeaways

Q3 operational sales grew 6%, which management said was ahead of analyst consensus; quarterly sales exceeded $25 billion.
Innovative Medicine grew 7.9%. Oncology sales rose approximately 17%, while RYBREVANT sales increased 64%.
Tremfya sales grew 68%; CAPLYTA reached $1 billion in year-to-date sales, and SPRAVATO grew 36%.
Management said J&J was on track to meet 2026 guidance and exceed $100 billion in annual revenue for the first time.
The supplied transcript ends during the MedTech discussion, so it does not provide the full segment results or CFO’s detailed guidance.

View recap

JPMorgan Chase & Co.

JPM Q3 2026

Reported: 2026-10-15

JPMorgan reported higher year-on-year revenue and earnings, while expenses and credit costs also rose. The stock was roughly flat, up 0.3% after earnings, reflecting a mixed picture rather than a clear market verdict.

Key takeaways

Net income was $15.3 billion, EPS was $5.57 and ROTCE was 20%; revenue of $50.9 billion rose 8% year on year, or 9% excluding $658 million of net investment securities losses.
Expenses increased 12% to $27.3 billion, driven largely by higher volume- and revenue-related costs, front-office hiring and wage inflation. Credit costs were $2.7 billion, including $2.2 billion of net charge-offs and a $539 million net reserve build.
CIB revenue rose 14% to $22.7 billion: investment banking fees increased 14% and equities revenue rose 49%, while fixed-income markets revenue fell 4%. Management said recent market conditions had slowed deal activity somewhat.
AWM revenue increased 14% to $6.9 billion; long-term net inflows were $51 billion and AUM reached $5.2 trillion, up 13% year on year.
For Q4, JPMorgan expects NII ex-markets of about $25.5 billion, total NII of about $28 billion and expenses of about $27.5 billion; it also gave a central 2027 NII ex-markets case of about $107 billion, while emphasizing the assumptions are highly uncertain.

View recap

Wells Fargo & Company

WFC Q3 2026

Reported: 2026-10-15

Wells Fargo shares fell 2.9%, a roughly flat reaction, as revenue growth was modest at 2% year over year and Markets slowed in the final weeks of the quarter. EPS rose 13% to $1.87, but the transcript does not identify a specific cause for the share-price move.

Key takeaways

Revenue increased 2% year over year, with growth in each operating segment; lower venture-capital investment revenue and lease income partly offset the gains.
EPS was $1.87, up 13% from a year ago; ROTCE was 16.3% for the quarter.
Average loans and deposits each grew 11% year over year. Consumer Banking and Lending revenue rose 5%, while Wealth and Investment Management revenue rose 12%.
Corporate and Investment Banking revenue increased 3%; Banking grew 8%, but Markets revenue was down modestly year over year after slowing in the last several weeks of the quarter.
Expenses declined modestly: nonrevenue-related expenses fell 4%, more than offsetting a 15% increase in revenue-related expenses.

View recap

Earnings Recaps

Domino's Pizza, Inc.

Johnson & Johnson

JPMorgan Chase & Co.

Wells Fargo & Company

Community

Earnings Recaps

Domino's Pizza, Inc.

Johnson & Johnson

JPMorgan Chase & Co.

Wells Fargo & Company

Community

Trending This Week

Notifications